WHO ICTRP trial
BK Viremia: Kinase Inhibition to Decrease Nephropathy Intervention Trial
ISRCTN40228609 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN40228609 |
|---|---|
| Public title | BK Viremia: Kinase Inhibition to Decrease Nephropathy Intervention Trial |
| Scientific title | BK Viremia: Kinase Inhibition to Decrease Nephropathy Intervention - a phase III multicentre randomised parallel group trial |
| Primary sponsor | University of Calgary (Canada) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Canada |
| Conditions | BK nephropathy Urological and Genital Diseases Unspecified nephritic syndrome |
| Interventions | Amended as of 17/08/2010: De novo transplant patients will have monthly measurements of urine or plasma BK virus at their centre. Once either urine or plasma is positive for BK, plasma will be sent to the central reference laboratory to… |
| Registration date | Feb 2, 2010 |
| Target size | 300 |
| Secondary IDs | MCT-99787; UC-NEPH-2009001 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: